300 related articles for article (PubMed ID: 27888619)
1. Tetraspanin CD151 as an emerging potential poor prognostic factor across solid tumors: a systematic review and meta-analysis.
Zeng P; Wang YH; Si M; Gu JH; Li P; Lu PH; Chen MB
Oncotarget; 2017 Jan; 8(3):5592-5602. PubMed ID: 27888619
[TBL] [Abstract][Full Text] [Related]
2. Impact of TROP2 expression on prognosis in solid tumors: A Systematic Review and Meta-analysis.
Zeng P; Chen MB; Zhou LN; Tang M; Liu CY; Lu PH
Sci Rep; 2016 Sep; 6():33658. PubMed ID: 27645103
[TBL] [Abstract][Full Text] [Related]
3. Tetraspanin CD151 expression associated with prognosis for patients with advanced gastric cancer.
Kang BW; Lee D; Chung HY; Han JH; Kim YB
J Cancer Res Clin Oncol; 2013 Nov; 139(11):1835-43. PubMed ID: 24005419
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis.
Zeng P; Li H; Lu PH; Zhou LN; Tang M; Liu CY; Chen MB
Sci Rep; 2017 Jun; 7(1):4223. PubMed ID: 28652617
[TBL] [Abstract][Full Text] [Related]
5. TMPRSS4 as an emerging potential poor prognostic factor for solid tumors: A systematic review and meta-analysis.
Zeng P; Zhang P; Zhou LN; Tang M; Shen YX; Jin J; Zhu YQ; Chen MB
Oncotarget; 2016 Nov; 7(46):76327-76336. PubMed ID: 27344186
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis.
Xiao J; Zou Y; Chen X; Gao Y; Xie M; Lu X; Li W; He B; He S; You S; Chen Q
PLoS One; 2016; 11(4):e0152674. PubMed ID: 27035914
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of CD151 overexpression in subtypes of invasive breast cancer.
Kwon MJ; Park S; Choi JY; Oh E; Kim YJ; Park YH; Cho EY; Kwon MJ; Nam SJ; Im YH; Shin YK; Choi YL
Br J Cancer; 2012 Feb; 106(5):923-30. PubMed ID: 22294188
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
10. PBK/TOPK overexpression and survival in solid tumors: A PRISMA-compliant meta-analysis.
Xu M; Xu S
Medicine (Baltimore); 2019 Mar; 98(10):e14766. PubMed ID: 30855480
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of octamer binding transcription factor 4 for patients with solid tumors: A meta-analysis.
Zhao X; Lu H; Sun Y; Liu L; Wang H
Medicine (Baltimore); 2020 Oct; 99(42):e22804. PubMed ID: 33080755
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of NEK2 in human solid tumors: a systematic review and meta-analysis.
Wang X; Chen K; Liu H; Huang Z; Chen X; Yin L
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30578380
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Ezrin in Various Cancers: A Systematic Review and Updated Meta-analysis.
Li J; Wei K; Yu H; Jin D; Wang G; Yu B
Sci Rep; 2015 Dec; 5():17903. PubMed ID: 26632332
[TBL] [Abstract][Full Text] [Related]
14. Association between Alpha B-crystallin expression and prognosis in patients with solid tumors: A protocol for systematic review and meta-analysis.
Yang M; Li Y; Tian F
Medicine (Baltimore); 2021 Feb; 100(7):e24831. PubMed ID: 33607849
[TBL] [Abstract][Full Text] [Related]
15. CD151 overexpression is associated with poor prognosis in patients with pT3 gastric cancer.
Ha SY; Do IG; Lee J; Park SH; Park JO; Kang WK; Choi MG; Lee JH; Bae JM; Kim S; Kim KM; Sohn TS
Ann Surg Oncol; 2014 Apr; 21(4):1099-106. PubMed ID: 24306658
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of hTERT overexpression in cancers: A systematic review and meta-analysis.
Wang K; Wang RL; Liu JJ; Zhou J; Li X; Hu WW; Jiang WJ; Hao NB
Medicine (Baltimore); 2018 Aug; 97(35):e11794. PubMed ID: 30170373
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of ANXA2 predicts adverse outcomes of patients with malignant tumors: a systematic review and meta-analysis.
Liu X; Ma D; Jing X; Wang B; Yang W; Qiu W
Med Oncol; 2015 Jan; 32(1):392. PubMed ID: 25476478
[TBL] [Abstract][Full Text] [Related]
18. Poor prognosis of nucleophosmin overexpression in solid tumors: a meta-analysis.
Chen S; He H; Wang Y; Liu L; Liu Y; You H; Dong Y; Lyu J
BMC Cancer; 2018 Aug; 18(1):838. PubMed ID: 30126359
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis.
Li L; Wu D; Yu Q; Li L; Wu P
Oncotarget; 2017 May; 8(19):32298-32308. PubMed ID: 28427178
[TBL] [Abstract][Full Text] [Related]
20. HOTAIR overexpression correlated with worse survival in patients with solid tumors.
Miao Z; Ding J; Chen B; Yang Y; Chen Y
Minerva Med; 2016 Dec; 107(6):392-400. PubMed ID: 27333150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
